Wright P A, Williams E D, Lemoine N R, Wynford-Thomas D
Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff, UK.
Oncogene. 1991 Mar;6(3):471-3.
Activated ras oncogenes in experimentally induced rodent tumours have been demonstrated to show specific patterns of oncogene activation which depend on the inducing agent, with H-ras activation in nitrosomethylurea (NMU) induced tumours, and K-ras activation in tumours induced by ionising radiation. We report a study of 12 radiation-associated human thyroid tumours, using polymerase chain reaction (PCR) amplification of paraffin-embedded material and allele-specific hybridisation with mutant-specific probes for the 3 ras oncogenes. Compared to 68 'spontaneous' human thyroid tumours, the radiation-associated cases show the same overall prevalence of ras mutation. However there is a significantly higher rate of K-ras mutation in radiation-associated follicular carcinomas than in 'spontaneous' follicular carcinomas (60% compared to 6%, P less than 0.05), suggesting that radiation may preferentially activate K-ras in human as well as rodent tumours.
在实验诱导的啮齿动物肿瘤中,已证明激活的ras癌基因显示出特定的癌基因激活模式,该模式取决于诱导剂,在亚硝基甲基脲(NMU)诱导的肿瘤中H-ras被激活,而在电离辐射诱导的肿瘤中K-ras被激活。我们报告了一项对12例辐射相关的人类甲状腺肿瘤的研究,使用聚合酶链反应(PCR)扩增石蜡包埋材料,并与针对3种ras癌基因的突变特异性探针进行等位基因特异性杂交。与68例“自发”人类甲状腺肿瘤相比,辐射相关病例中ras突变的总体发生率相同。然而,辐射相关的滤泡癌中K-ras突变率明显高于“自发”滤泡癌(分别为60%和6%,P<0.05),这表明辐射可能在人类和啮齿动物肿瘤中优先激活K-ras。